Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IMPROVE-T2D Study: Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes

NCT03620773 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT03620773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03620773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IMPROVE-T2D Study: Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes
Lead sponsor
University of Colorado, Denver
Phase
Phase 1/2
Overall status
Completed
Start date
October 1, 2018
Completion date
September 25, 2024
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adolescent obesity, bariatric surgery candidate, diabetes complications, diabetes mellitus, diabetes mellitus, type 2, diabetic kidney disease, diabetic nephropathies, nephropathy, obesity, pediatric obesity, type 2 diabetes mellitus, weight loss